CardaBit

CardaBit

TBA
795 Views
CardaBit $CABTC is a Cardano token made for the big price pumps by creating reserves in $BTC and $ADA and using the BuyBack strategy!
1.4
TOTAL SCORE
1.9
ICO PROFILE

(weight: 45%)

1
TEAM PROOF

(weight: 20%)

Get widget
Token info
Ticker: CABTC
Platform: Cardano
Financial
Pre-sale Price : 1 CABTC – 0.1 ADA
Bonuses: All 10,000+ $CABTC Pre-Sale token holders will get a 30% bonus airdropped to their wallets on the 1st of January 2024!
Social media
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Active
KardiaChain
KardiaChain is the blockchain of blockchains. A scalable and interoperable blockchain platform for decentralized applications. Our Vision: We believe Blockchain can create equal opportunities for people, a world where people have access to opportunity to invest, to start a business, to work and to be socially mobile. Our technology empowers mass adoption, expand use-cases and lay foundation of the blockchain ecosystem. We are building a blockchain platform for decentralised applications helping to create a blockchain ecosystem that allows for scaling and connecting disparate blockchains. Our Core Technology is: - Dual Node - Elastic Sharding With Incentive Mechanism (ESWIM) - Kardia Smart Contract Markup Language (KSML) Our Use cases are: - Supply Chain Management - Fully Decentralised Cross-chain Exchange - Smart City
Upcoming
Coolomat
Coolomat Market will change the online e-commerce grocery sector with an innovative approach connecting customers and producers, big and small, over a new innovative online platform utilizing blockchain technology and open source software. A big “game changer” is the connection to physical click & collect pick up point devices – Coolomats. Our devices present the first and the only worldwide network of such kind.
Upcoming
Nice 1
At its core, Nice 1 is a blockchain game development platform. When using Nice 1, a game developer can raise funds from public and private supporters. However, Nice 1 goes further than just mere fundraising. The Nice 1 blockchain provides users with access to an SDK library (and documentation) for Unreal Engine & Unity. Nice 1 is striving to create state-of-the-art gaming services for streamers and esports enthusiasts. Non-game developers can earn and support gamers and developers, by helping support the Nice 1 blockchain network. The primary goal of Nice 1, is to promote innovation in gaming worldwide. However, in the process, Nice 1 is also striving to tackle increasing censorship in gaming.
Upcoming
Retreeb
Founded in 2019 Retreeb is a sustainable fintech. We develop a decentralized, simple and sustainable mobile payment method. It is a free payment service for consumers and relies on a multi-local stablecoin network and Fantom's infrastructure. It allows its users to act in accordance with the universal values of ethics, sharing and solidarity.
Upcoming
Beyond Seen Screen
Beyond Seen Screen has created a platform that enables interactivity with video content. With Beyond Seen Screen watching video content is no longer a passive action, a one-way street. The platform enables content producers and content distribution companies to link additional information to the video content. Viewers will no longer only passively receive adverts, trailers and other video content but will have ability to interactively engage with them by using their mobile device.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.